News Archive

Americans likely to need COVID-19 booster, officials say, but questions abound

Dr. Diemert and other infectious disease experts discuss the search for a universal COVID-19 vaccine and comparisons to the seasonal influenza vaccine.

Monkeypox Myths and Facts: What You Need to Know

Doreen Gentzler, NBC4 News Anchor, interviews GW VRU Director, Dr. David Diemert on monkeypox myths and facts.

FDA Clears Moderna, Pfizer Covid Shots for Children 5 and Under

Long-awaited protection for tots appears close to arrival. Moderna also get clearance for vaccine for 6- to 17-year olds.

The Most Common Questions About The Novavax COVID Vaccine, Answered

How is the shot different from Pfizer, Moderna and J&J? Does it work against new variants? Here's what to know.

Moderna Announces Omicron-Containing Bivalent Booster Candidate mRNA-1273.214 Demonstrates Superior Antibody Response Against Omicron

Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced new clinical data on its Omicron-containing bivalent COVID booster candidate, mRNA-1273.214, containing mRNA-1273 (Spikevax) and a vaccine candidate targeting the…

A gloved hand holding a COVID-19 vaccine booster vial and syringe
GW School of Medicine and Health Sciences and the GW MFA Serve as one of 24 participating trial sites for the NIAID’s COVAIL Trial

The GW School of Medicine and Health Sciences has been selected to serve as one of 24 participating sites for the Phase 2 clinical trial to evaluate additional COVID-19 booster shots in adults, including multiple vaccines based on viral variants such as Delta and Omicron.

Pharmaceutical pills resting on a surface labeled 'HIV / Aids'
The hunt for an AIDS vaccine approaches 40 with hope and caution

Scientists created a COVID-19 vaccine in under a year, but there remains no vaccine to stop the AIDS virus. Experts explain how HIV eludes defeat and describe their latest strategies.

A person holding a heart-shaped card labeled 'Booster' with a syringe icon next to their arm with a bandage
NIH Begins Clinical Trial Evaluating Second COVID-19 Booster Shots in Adults

A Phase 2 clinical trial evaluating various additional COVID-19 booster shots has begun enrolling adult participants in the United States. The trial aims to understand if different vaccine regimens—prototype and variant vaccines alone and in combinations—can broaden immune responses in adults…

First Patients Vaccinated in Clinical Trial of Experimental HIV Vaccine

Dr. David Diemert, director of The GW Vaccine Research Unit, was interviewed on CTV Your Morning about our current clinical trial of an experimental HIV vaccine.

“The future implications are huge if we could have an effective HIV vaccine that would prevent people from getting the…

University administers first doses of mRNA HIV vaccine through Moderna partnership

George Washington University has collaborated with Moderna to test the safety of the first mRNA HIV vaccines and the immune responses of two participants in the Phase 1 clinical trial. Four institutions, including GW, have enrolled 56 HIV-negative adult participants for the vaccines’ clinical…